Status:
ACTIVE_NOT_RECRUITING
Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Cancer
Cancer of Pancreas
Eligibility:
All Genders
18+ years
Brief Summary
PURPOSE: To determine the prognostic properties of a comprehensive evaluation of body composition and physical function in patients with GI-HEP cancer from point of diagnosis and throughout the treatm...
Detailed Description
RATIONAL: Patients diagnosed with GI-HEP cancer are faced with poor prognosis. The treatment is demanding and associated with severe deconditioning potentially leading to worse prognostic outcomes. To...
Eligibility Criteria
Inclusion
- Patients diagnosed with histologically verified GI-HEP cancer
Exclusion
- Age: \<18
- Pregnancy
- Physical or mental disabilities precluding physical testing
- Inability to read and understand Danish
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03347162
Start Date
December 1 2017
End Date
December 31 2026
Last Update
June 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark